LAUSANNE, Switzerland--(BUSINESS WIRE)--Mar. 31, 2017--
Philip Morris International Inc. (“PMI”) (NYSE / Euronext Paris: PM)
submitted a Premarket Tobacco Product Application (PMTA) for its
Electronically Heated Tobacco Product (EHTP) to the US Food and Drug
Administration’s (FDA) Center for Tobacco Products. This is consistent
with the Company’s stated goal of submitting its PMTA in the first
Quarter of 2017.
PMI’s PMTA seeks authorization to commercialize the EHTP in the United
States. Should FDA grant the requested marketing order, Altria Group
Inc. would be responsible for commercializing and marketing the product
in the United States under the terms of a licensing agreement with PMI.
Note to editor
On December 5, 2016, PMI submitted a Modified Risk Tobacco Product
(MRTP) application for its EHTP to the FDA. Administrative review of
that application is ongoing. A PMTA marketing order is a prerequisite to
commercializing a new tobacco product such as PMI’s EHTP. A decision on
the PMTA would allow the marketing of PMI’s EHTP without modified risk
claims independent of a decision on the MRTPA.
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the world’s leading
international tobacco company, with six of the world's top 15
international brands and products sold in more than 180 markets. In
addition to the manufacture and sale of cigarettes, including Marlboro,
the number one global cigarette brand, and other tobacco products, PMI
is engaged in the development and commercialization of Reduced-Risk
Products (RRPs). RRPs is the term PMI uses to refer to products that
present, are likely to present, or have the potential to present less
risk of harm to smokers who switch to these products versus continued
smoking. Through multidisciplinary capabilities in product development,
state-of-the-art facilities, and industry-leading scientific
substantiation, PMI aims to provide an RRP portfolio that meets a broad
spectrum of adult smoker preferences and rigorous regulatory
requirements. For more information, see www.pmi.com
and www.pmiscience.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170331005528/en/
Source: Philip Morris International
Media enquiries
Philip Morris International Media Office
T:
+41 (0)58 242 4500
E: media@pmi.com